Showing 1 - 8 results of 8 for search 'Nicolas Gilles', query time: 0.06s Refine Results
  1. 1
    Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases

    Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases by Nicolas Gilles

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Brain processing of emotional scenes in aging: effect of arousal and affective context.

    Brain processing of emotional scenes in aging: effect of arousal and affective context. by Nicolas Gilles Mathieu, Edouard Gentaz, Sylvain Harquel, Laurent Vercueil, Alan Chauvin, Stéphane Bonnet, Aurélie Campagne

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Structural and Functional Diversity of Animal Toxins Interacting With GPCRs

    Structural and Functional Diversity of Animal Toxins Interacting With GPCRs by Anne-Cécile Van Baelen, Philippe Robin, Pascal Kessler, Arhamatoulaye Maïga, Arhamatoulaye Maïga, Nicolas Gilles, Denis Servent

    Published 2022-02-01
    Get full text
    Article
  4. 4
    Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins

    Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins by Guillaume Blanchet, Doria Alili, Adèle Protte, Gregory Upert, Nicolas Gilles, Livia Tepshi, Enrico A. Stura, Gilles Mourier, Denis Servent

    Published 2017-06-01
    Get full text
    Article
  5. 5
    Characterization of the First Animal Toxin Acting as an Antagonist on AT1 Receptor

    Characterization of the First Animal Toxin Acting as an Antagonist on AT1 Receptor by Anne-Cécile Van Baelen, Xavier Iturrioz, Marion Chaigneau, Pascal Kessler, Catherine Llorens-Cortes, Denis Servent, Nicolas Gilles, Philippe Robin

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors.

    Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors. by Carole Fruchart-Gaillard, Gilles Mourier, Guillaume Blanchet, Laura Vera, Nicolas Gilles, Renée Ménez, Elodie Marcon, Enrico A Stura, Denis Servent

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Evaluation of the Spider (<i>Phlogiellus</i> genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug Candidates

    Evaluation of the Spider (<i>Phlogiellus</i> genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug Candidates by Tânia C. Gonçalves, Pierre Lesport, Sarah Kuylle, Enrico Stura, Justyna Ciolek, Gilles Mourier, Denis Servent, Emmanuel Bourinet, Evelyne Benoit, Nicolas Gilles

    Published 2019-08-01
    Get full text
    Article
  8. 8
    MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteries

    MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteries by Justyna Ciolek, Claude Zoukimian, Justine Dhot, Mélanie Burban, Mathilde Triquigneaux, Benjamin Lauzier, Christelle Guimbert, Didier Boturyn, Marine Ferron, Lidia Ciccone, Livia Tepshi, Enrico Stura, Pierre Legrand, Philippe Robin, Gilles Mourier, Béatrice Schaack, Imen Fellah, Guillaume Blanchet, Chantal Gauthier-Erfanian, Rémy Beroud, Denis Servent, Michel De Waard, Nicolas Gilles

    Published 2022-06-01
    Get full text
    Article

Search Tools: